API Innovation Center

Next week, the API Innovation Center will be attending DCAT Week, a gathering for companies engaged in the global bio/pharmaceutical manufacturing value chain hosted by DCAT (Drug, Chemical & Associated Technologies Association). This event is an opportunity for us to build connections and grow our ecosystem of collaborators. We look forward to sharing our innovative work in advanced manufacturing with others and discussing how we are driving economic growth and creating new jobs in the Missouri region. #DCATWeek #APIInnovationCenter #AdvancedManufacturing #Innovation

The API Innovation Center was joined by Corning Incorporated and Waters Corporation at the opening of our Research and Development lab at University of Missouri-Saint Louis last week. During the lab tours, Corning’s Jeremy West showcased their state-of-the-art lab equipment and Waters’ Elizabeth Bergman explained their cutting-edge analytical equipment. Utilizing these advanced technologies from Corning and Waters, APIIC is developing advanced manufacturing processes that will help to revolutionize the pharmaceutical manufacturing industry. Their continued support of our mission strengthens our efforts to ensure every hospital, pharmacy and patient has access to high-quality domestically produced critical medication. We are grateful for their partnership in advancing national health security and driving innovation in the industry. #PharmaceuticalManufacturing #AdvancedManufacturing #AMT #Innovation #APIInnovationCenter

Missouri’s collaborative innovation ecosystem is setting a national example for reshoring pharmaceutical manufacturing and strengthening the U.S. pharmaceutical supply chain.??? Learn more ?? https://lnkd.in/gXsCs43J #PharmaceuticalInnovation #APImanufacturing #Missouri #HealthcareReshoring #Biopharma #SupplyChainSecurity

Last week, the API Innovation Center published our market research paper, "Benefits and Barriers to Adopting Advanced Manufacturing Technology in the Pharmaceutical Industry," an analysis of the opportunities and obstacles associated with the adoption of Advanced Manufacturing Technologies (AMTs) in the U.S. pharmaceutical industry. According to our survey conducted with PharmaACE, many respondents see the benefits of adopting AMTs, with 90% citing increased efficiency as extremely beneficial and 83% seeing ease of scale up as an extreme benefit. Still, 78% of respondents cited regulatory uncertainty, particularly in navigating FDA approval processes for facilities transitioning from batch manufacturing, as a major barrier to adopting AMTs. This underscores the importance of strengthening collaboration with regulatory bodies like the FDA to streamline approval processes for AMTs and receive necessary documentation and validation. Read the full paper to learn more about the benefits and barriers to AMT adoption: https://lnkd.in/eDYGtG9t #PharmaceuticalManufacturing #AdvancedManufacturing #AMT #Innovation #APIInnovationCenter

Want to stay up to date on what the API Innovation Center is working on? Each month, APIIC shares our latest news and updates with our subscribers. We also spotlight industry, research and updates on other members of our ecosystem. Sign up for our newsletter here: https://lnkd.in/e5FTfWw4

Today, the API Innovation Center and the University of Missouri-Saint Louis unveiled their new state-of-the-art Research and Development lab dedicated to advancing small-molecule active pharmaceutical ingredients. The lab will support the expansion of APIIC's research and development capabilities and leverage advanced manufacturing technology to further strengthen domestic pharmaceutical innovation and production while also providing UMSL students hands-on learning and training opportunities that can prepare them for careers in the pharmaceutical space. Thank you to all who joined us today. This lab opening is a critical step forward in advancing domestic pharmaceutical production and strengthening our national health security. It’s a testament to the power of collaboration between industry, academia and government. We are proud to be a driving force in the growth and innovation of the St. Louis region together with our collaborators. A special thank you to UMSL for their collaboration and commitment to advancing pharmaceutical innovation in the St. Louis region has been instrumental to our efforts. We’re grateful for the opportunity to work alongside such an exceptional institution and look forward to continued collaboration. Read the full release on our website: https://lnkd.in/dh5HAh9E Missouri Senate, Missouri House of Representatives, Corning Incorporated, Waters Corporation #Missouri #PharmaceuticalManufacturing #APIInnovationCenter #AdvancedManufacturing #HealthSecurity

The Missouri Times spoke with the API Innovation Center about our efforts to bolster domestic pharmaceutical manufacturing and strengthen national health security by reducing reliance on foreign manufacturing. With support from the state of Missouri, we are utilizing innovative advanced manufacturing technologies to improve the quality and efficiency of drug manufacturing, all while bringing jobs and investment back to the state. Read the full article on our website: https://lnkd.in/ebNrSA9f #Missouri #PharmaceuticalManufacturing #APIInnovationCenter #AdvancedManufacturing #HealthSecurity

“Making our own medicines is one of the most significant economic stimulus efforts that we can put in place for our nation and our state,” said Anthony Sardella during an informational hearing with the Missouri House Emerging Issues Committee. Thank you to the Missouri Chamber of Commerce and Industry for highlighting how the Show Me State has become a national leader in reshoring critical medicines, and their support along the way. https://lnkd.in/gd37XEkJ

This week, the API Innovation Center appeared in front of the Emerging Issues Committee of the Missouri House of Representatives for an informational hearing. We spoke to our progress in securing the nation's pharmaceutical supply chain, crucial work that we are able to advance thanks to support from the State of Missouri. In just three years, we’ve made remarkable progress, with six molecules currently in development, and in the next five years, we’re aiming to develop 25 molecules, generating an estimated $1.2 billion impact in our state. We’re excited about the future and our continued partnership with Missouri to strengthen national health security and fuel economic growth. Read more about the hearing on our website: https://lnkd.in/gk8dZABz #Missouri #EconomicGrowth #HealthSecurity #PharmaceuticalManufacturing #APIs #Innovation #APIInnovationCenter

We're #hiring a new Senior Analytical Chemist in St Louis, Missouri. Apply today or share this post with your network.